AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16697307 — intervention group
Group type: COMPARATOR
Intervention: Conventional right ventricular (RV) pacing
Number of subjects: 30
Study 15177822 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticobasal degeneration (CBD)
Number of subjects: 16
Study 15177822 — intervention group
Group type: COMPARATOR
Intervention: Healthy adults (control group)
Number of subjects: 16
Study 11878522 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 321
Study 11878522 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 321
Study 9777474 — intervention group
Group type: EXPERIMENTAL
Intervention: California Verbal Learning Test (CVLT) indices for detecting malingered head injury
Number of subjects: 90
Study 9777474 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic cutoff scores for Recognition Discriminability and Recognition Hits
Number of subjects: 90
Study 9777474 — intervention group
Group type: EXPERIMENTAL
Intervention: Indices based on subtle principles of learning theory
Number of subjects: 90
Study 9777474 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a simple instructional set
Number of subjects: 90
Study 7530469 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative radiotherapy (3 x 5 Gy over 5 days within 2 days of operation) followed by surgery
Number of subjects: 468
Study 7530469 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 468
Study 3046816 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine, 300 mg
Number of subjects: 10
Study 3046816 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, 10 mg
Number of subjects: 10
Study 3046816 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, 10 mg with caffeine pretreatment
Number of subjects: 10
Study 3046816 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine, 10 mg with placebo pretreatment
Number of subjects: 10
Study 3046816 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine pretreatment
Number of subjects: 10
Study 3046816 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 10
Study 30316010 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy (3 mg/kg every 2 weeks)
Number of subjects: 109
Study 28609401 — intervention group
Group type: EXPERIMENTAL
Intervention: MISC (mediational intervention for sensitizing caregivers)
Number of subjects: 0
Study 28609401 — intervention group
Group type: COMPARATOR
Intervention: Nutrition curriculum (control)
Number of subjects: 0
Study 25357214 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP target of 85 mmHg (HLH group)
Number of subjects: 16
Study 25357214 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP target of 65 mmHg (LHL group)
Number of subjects: 16
Study 25357214 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion (LHL group)
Number of subjects: 16
Study 22985213 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (0.6 mg)
Number of subjects: 1091
Study 22985213 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.2 mg)
Number of subjects: 1091
Study 22985213 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg)
Number of subjects: 1091
Study 22985213 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 1091
Study 22985213 — intervention group
Group type: COMPARATOR
Intervention: Metformin monotherapy
Number of subjects: 1091
Study 22069291 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0
Study 22069291 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study 19140039 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt capsules
Number of subjects: 46
Study 19140039 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 46
Study 16169629 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea consumption
Number of subjects: 0
Study 15282425 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 French guiding catheters
Number of subjects: 216
Study 15282425 — intervention group
Group type: COMPARATOR
Intervention: 6 French guiding catheters
Number of subjects: 216
Study 11694150 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified poloxamer 188
Number of subjects: 255
Study 11694150 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 255
Study 11694150 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified poloxamer 188 in children aged 15 years or younger
Number of subjects: 255
Study 11694150 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified poloxamer 188 in patients receiving hydroxyurea
Number of subjects: 255
Study 9030834 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice per day)
Number of subjects: 9
Study 7910732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy followed by in vivo exposure
Number of subjects: 24
Study 7910732 — intervention group
Group type: COMPARATOR
Intervention: Associative therapy followed by in vivo exposure
Number of subjects: 24
Study 7910732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy alone
Number of subjects: 24
Study 7910732 — intervention group
Group type: COMPARATOR
Intervention: Associative therapy alone
Number of subjects: 24
Study 7910732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy combined with in vivo exposure
Number of subjects: 24
Study 7910732 — intervention group
Group type: COMPARATOR
Intervention: Associative therapy combined with in vivo exposure
Number of subjects: 24
Study 3112261 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal in combination with bupivacaine
Number of subjects: 16
Study 3112261 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol with codeine and lignocaine
Number of subjects: 16
Study 30938127 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 16
Study 30938127 — intervention group
Group type: COMPARATOR
Intervention: Gluten-containing diet
Number of subjects: 16
Study 28163108 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-enriched milk (2×20g protein/d)
Number of subjects: 31
Study 28163108 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric carbohydrate drink
Number of subjects: 31
Study 26078236 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track surgery model based on preoperative nutritional risk screening (NRS 2002)
Number of subjects: 180
Study 26078236 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (control group)
Number of subjects: 180
Study 23943730 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline with pindolol
Number of subjects: 62
Study 23943730 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 62
Study 23943730 — intervention group
Group type: COMPARATOR
Intervention: Surrogate placebo (loratadine)
Number of subjects: 62
Study 21879200 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 17
Study 21879200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 19277420 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmoteplase 180 microg/kg
Number of subjects: 34
Study 19277420 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmoteplase 250 microg/kg
Number of subjects: 34
Study 19277420 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmoteplase (higher doses)
Number of subjects: 34
Study 19277420 — intervention group
Group type: COMPARATOR
Intervention: Alteplase 100 mg
Number of subjects: 34
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Depth jumps from 46 cm
Number of subjects: 6
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Depth jumps from 61 cm
Number of subjects: 6
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Pike jump
Number of subjects: 6
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuck jump
Number of subjects: 6
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐leg jump
Number of subjects: 6
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Countermovement jump
Number of subjects: 6
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat jump
Number of subjects: 6
Study 17685678 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat jump holding dumbbells equal to 30% of 1 RM
Number of subjects: 6
Study 17685678 — intervention group
Group type: COMPARATOR
Intervention: All exercises
Number of subjects: 6
Study 15012646 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate PLA injections (weeks 0, 2, and 4)
Number of subjects: 30
Study 15012646 — intervention group
Group type: COMPARATOR
Intervention: Delayed PLA injections (weeks 12, 14, and 16)
Number of subjects: 30
Study 15012646 — intervention group
Group type: EXPERIMENTAL
Intervention: Both immediate and delayed PLA injections
Number of subjects: 30
Study 11376522 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-Based Medicine
Number of subjects: 0
Study 9604056 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile dual-energy X-ray absorptiometry (DXA) unit for osteoporosis screening
Number of subjects: 1774
Study 9604056 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile DXA unit
Number of subjects: 1774
Study 8243375 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate (FBM)
Number of subjects: 0
Study 8243375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8243375 — intervention group
Group type: COMPARATOR
Intervention: Low-dosage valproate (VPA)
Number of subjects: 0
Study 3038003 — intervention group
Group type: EXPERIMENTAL
Intervention: Sultamicillin
Number of subjects: 52
Study 3038003 — intervention group
Group type: COMPARATOR
Intervention: Cloxacillin
Number of subjects: 52
Study 31910302 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous functional electrical stimulation for 8 weeks (5 days a week)
Number of subjects: 14
Study 31910302 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous functional electrical stimulation for 4 weeks of ineffective stimulation followed by 4 weeks of effective training
Number of subjects: 14
Study 30475965 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies (men)
Number of subjects: 7271
Study 30475965 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies (women)
Number of subjects: 7271
Study 30475965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention studies (men)
Number of subjects: 7271
Study 30475965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention studies (women)
Number of subjects: 7271
Study 30475965 — intervention group
Group type: EXPERIMENTAL
Intervention: All studies
Number of subjects: 7271
Study 25790724 — intervention group
Group type: COMPARATOR
Intervention: Leucine-enriched whey protein (150 kcal)
Number of subjects: 12
Study 25790724 — intervention group
Group type: COMPARATOR
Intervention: Leucine-enriched whey protein (320 kcal)
Number of subjects: 12
Study 25790724 — intervention group
Group type: COMPARATOR
Intervention: Low-caloric products
Number of subjects: 12
Study 24892221 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrokinesytherapy (3 times/week) in addition to conventional physical therapy (3 times/week)
Number of subjects: 0
Study 24892221 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (6 times/week)
Number of subjects: 0
Study 22364561 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based modified constraint-induced movement therapy plus trunk restraints (3 hours/day, 5 days/week for 2 weeks)
Number of subjects: 0
Study 22364561 — intervention group
Group type: COMPARATOR
Intervention: Home-based modified constraint-induced movement therapy (3 hours/day, 5 days/week for 2 weeks)
Number of subjects: 0
Study 22364561 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based modified constraint-induced movement therapy plus trunk restraints
Number of subjects: 0
Study 22364561 — intervention group
Group type: COMPARATOR
Intervention: Home-based modified constraint-induced movement therapy
Number of subjects: 0
Study 20164787 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan plus bepridil (n = 52)
Number of subjects: 153
Study 20164787 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol plus bepridil (n = 51)
Number of subjects: 153
Study 20164787 — intervention group
Group type: COMPARATOR
Intervention: Bepridil alone (n = 50)
Number of subjects: 153
Study 20164787 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 153
Study 20164787 — intervention group
Group type: COMPARATOR
Intervention: Bepridil group vs. Candesartan group
Number of subjects: 153
Study 18549462 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing-gum
Number of subjects: 93
Study 18549462 — intervention group
Group type: COMPARATOR
Intervention: Control (no chewing-gum)
Number of subjects: 93
Study 16098314 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) assessment
Number of subjects: 56
Study 16098314 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up TEE examinations
Number of subjects: 56
Study 16098314 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant and/or antiplatelet treatment
Number of subjects: 56
Study 12393567 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (Cy)
Number of subjects: 21
Study 12393567 — intervention group
Group type: COMPARATOR
Intervention: Antithymocyte globulin (ATG)
Number of subjects: 21
Study 10343421 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief advice from a GP plus extended counselling and follow‐up from a trained practice nurse
Number of subjects: 497
Study 10343421 — intervention group
Group type: COMPARATOR
Intervention: Brief advice from a GP alone
Number of subjects: 497
Study 10343421 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended counselling
Number of subjects: 497
Study 10343421 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 497
Study 7551845 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime (1.5 g intravenously 20 min before TPB)
Number of subjects: 111
Study 7551845 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (4.5 g intravenously 20 min before TPB)
Number of subjects: 111
Study 7551845 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 111
Study 7551845 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam
Number of subjects: 111
Study 1433582 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment (155 children)
Number of subjects: 321
Study 1433582 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (151 children)
Number of subjects: 321
Study 3912622 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo‐endocrine therapy (CMFp + T)
Number of subjects: 463
Study 3912622 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy (p + T)
Number of subjects: 463
Study 3912622 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 463
Study 31004264 — intervention group
Group type: EXPERIMENTAL
Intervention: MindOut program
Number of subjects: 497
Study 29291706 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary care program
Number of subjects: 263
Study 24120032 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted diet enriched in n-3 PUFAs (20 kcal/kg/ideal body weight/day, average 2.6 g/d)
Number of subjects: 44
Study 23174637 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 258
Study 23174637 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive strategy
Number of subjects: 258
Study 23174637 — intervention group
Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 258
Study 20626424 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless protocol with immediate loading (test)
Number of subjects: 14
Study 20626424 — intervention group
Group type: COMPARATOR
Intervention: Conventional protocol with loading after 6 weeks (control)
Number of subjects: 14
Study 17716943 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 3029
Study 17716943 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 3029
Study 15826234 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC nonwords (e.g., pof)
Number of subjects: 0
Study 15826234 — intervention group
Group type: EXPERIMENTAL
Intervention: CCVC frame (e.g., grof)
Number of subjects: 0
Study 15826234 — intervention group
Group type: EXPERIMENTAL
Intervention: CVCC frame (e.g., goft)
Number of subjects: 0
Study 12505234 — intervention group
Group type: EXPERIMENTAL
Intervention: PAT-enhanced diagnosis
Number of subjects: 616
Study 12505234 — intervention group
Group type: COMPARATOR
Intervention: ECG alone
Number of subjects: 616
Study 9649987 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (1.5 micrograms kg‐1)
Number of subjects: 12
Study 9649987 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (1.5 micrograms kg‐1) + Clonidine (3 micrograms kg‐1)
Number of subjects: 12
Study 9649987 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl alone (1.5 micrograms kg‐1)
Number of subjects: 12
Study 8036288 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline inhaled by Turbuhaler (5 doses = 2.5 mg, t.i.d. for 2 weeks)
Number of subjects: 40
Study 8036288 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline inhaled by Turbuhaler
Number of subjects: 40
Study 2844076 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic-index (GI) dinners
Number of subjects: 0
Study 2844076 — intervention group
Group type: COMPARATOR
Intervention: High-glycemic-index (GI) dinners
Number of subjects: 0
Study 31691019 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg kg‐1)
Number of subjects: 13
Study 31691019 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 13
Study 29571930 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) intervention with tailored text messages
Number of subjects: 28
Study 29571930 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 29141611 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BoNT-A) 200 units in paravertebral muscles
Number of subjects: 19
Study 29141611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 26325649 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint combined with cognitive behavioral therapy
Number of subjects: 22
Study 26325649 — intervention group
Group type: COMPARATOR
Intervention: Occlusal splint alone
Number of subjects: 22
Study 23973010 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 13
Study 23973010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 21511002 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg of bromazepam
Number of subjects: 14
Study 21511002 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 14
Study 18312043 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct switch (DS)
Number of subjects: 368
Study 18312043 — intervention group
Group type: EXPERIMENTAL
Intervention: Start-taper switch (STS)
Number of subjects: 368
Study 17002053 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial pneumoperitoneum (PP) with chemotherapy
Number of subjects: 138
Study 17002053 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only (Control)
Number of subjects: 138
Study 14530471 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc‐WBC scintigraphy
Number of subjects: 313
Study 10919343 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamicin 500 mg (test formulation)
Number of subjects: 24
Study 10919343 — intervention group
Group type: COMPARATOR
Intervention: Biaxin 500 mg (reference formulation)
Number of subjects: 24
Study 9208531 — intervention group
Group type: EXPERIMENTAL
Intervention: Qiwei Baizhu Powder (QWBZP)
Number of subjects: 60
Study 9208531 — intervention group
Group type: COMPARATOR
Intervention: Oral Rehydration Solution (ORS)
Number of subjects: 60
Study 1603294 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressant treatment (Imipramine)
Number of subjects: 0
Study 4036778 — intervention group
Group type: EXPERIMENTAL
Intervention: Group type A behavior counseling for 9 months
Number of subjects: 118
Study 4036778 — intervention group
Group type: COMPARATOR
Intervention: No counseling (Control)
Number of subjects: 118
Study 4036778 — intervention group
Group type: EXPERIMENTAL
Intervention: Group type A behavior counseling
Number of subjects: 118
Study 29553223 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD-CAM insole
Number of subjects: 67
Study 29553223 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional insole
Number of subjects: 67
Study 29553223 — intervention group
Group type: COMPARATOR
Intervention: Sham insole
Number of subjects: 67
Study 29553223 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (CAD-CAM, Conventional, Sham)
Number of subjects: 67
Study 28858981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment
Number of subjects: 0
Study 28858981 — intervention group
Group type: COMPARATOR
Intervention: Control (standard treatment not specified)
Number of subjects: 0
Study 27936083 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling on physical activity and diet and weight gain at five antenatal visits
Number of subjects: 173
Study 24610683 — intervention group
Group type: COMPARATOR
Intervention: InsuPatch device on day 1
Number of subjects: 56
Study 24610683 — intervention group
Group type: EXPERIMENTAL
Intervention: InsuPatch device on day 3
Number of subjects: 56
Study 22613740 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-down bed rest (HDBR) for 24 hours
Number of subjects: 17
Study 22613740 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic treatment (spironolactone, 100 mg day(-1) for 3 days)
Number of subjects: 17
Study 22613740 — intervention group
Group type: COMPARATOR
Intervention: Lower body negative pressure treatments (LBNP, -15 and -35 mmHg)
Number of subjects: 17
Study 20553617 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based fatigue management intervention (6 sessions)
Number of subjects: 180
Study 20553617 — intervention group
Group type: COMPARATOR
Intervention: Current local practice
Number of subjects: 180